Trials / Conditions / Recurrent Lung Adenocarcinoma
Recurrent Lung Adenocarcinoma
5 registered clinical trials studyying Recurrent Lung Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 7 NCT04533451 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent NCT03845296 | SWOG Cancer Research Network | Phase 2 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurre NCT03110978 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired R NCT03076164 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage NCT00946712 | SWOG Cancer Research Network | Phase 3 |